A breakthrough mRNA cancer vaccine has shown the ability to supercharge the effects of immunotherapy in mice, sparking hope for a universal “off-the-shelf” treatment that could fight multiple cancers.
Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, first-in-class small molecule drugs that inhibit hypoxia-inducible factors 1 ...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being ...
Share on Pinterest Could an experimental drug trio fight difficult-to-treat pancreatic cancer? Experiments in mouse models show promise. Image credit: adamkaz/Getty Images Pancreatic ductal ...
Spanish scientists say they have developed a potential breakthrough cure for treating pancreatic cancer, but the new therapy isn't ready for human use yet. Pancreatic cancer forms tumors in the ...
Chimeric antigen receptor (CAR) T-cell therapy is an impactful treatment for blood cancers, such as leukemia and lymphoma. However, the immunotherapy has struggled against solid tumors, as tumor cells ...
Somewhere in an operating room this spring, a neurosurgeon did something that has never been done before: while removing a ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A vaccine using tiny particles has been shown to effectively prevent ...
Long-term survivors in both oral PV-10 arms showed an absence of gross bladder tumor at necropsy, a finding not observed in any untreated, ...